Novel approach for estrogen-receptor-positive breast cancer reported
Thursday, December 11, 2014 - 15:31
in Health & Medicine
Promising results from a novel therapeutic approach for women with estrogen-receptor-positive breast cancer have been reported by scientists. The new approach, a new drug class called gamma secretase inhibitors (GSI), specifically inhibits Notch and shuts down critical genes and cancer cells responsible for tumor growth.